Volume 15, Number 11—November 2009
Research
Screening Practices for Infectious Diseases among Burmese Refugees in Australia
Nadia J. Chaves1, Katherine B. Gibney1, Karin Leder, Daniel P. O’Brien, Caroline Marshall, and Beverley-Ann Biggs
Table 2
Proportion of patients with selected conditions compared with other studies of Burmese immigrants, retrospective cohort study, Australia, 2004–2008*
| Condition | This study, no. positive/ no. tested (%), N = 156 | Denburg study (6), % positive, N = 68 | Minnesota Department of Health study (7), % positive, N = 159 |
|---|---|---|---|
| Helicobacter pylori infection | 33/41 (80.5) | ||
| Latent TB | 105/149 (70.5) | 28 | 52 |
| Vitamin D deficiency | 55/147 (37.4) | ||
| Eosinophilia | 55/155 (35.5) | 50 | |
| Strongyloides infection (serology) | 39/150 (26.0) | 7.5 | |
| Stool parasites (pathology) | 33/137 (24.1) | 32 | 18 |
| Chronic HBV infection | 20/141 (14.2) | 13 | 9 |
| Isolated core antibody against HBV | 18/141 (12.8) | ||
| Schistosomiasis (serology) | 8/147 (5.4) | ||
| HCV infection | 4/145 (2.8) | ||
| Active TB | 3/149 (2.0) | ||
| Syphilis | 2/137 (1.5) | 0 | <1 |
| Malaria | 1/117 (0.9) | ||
| HIV infection | 1/145 (0.7) | ||
| Chlamydia infection/gonorrhea | 0/99 (0.0) |
*TB, tuberculosis; HBV, hepatitis B virus; HCV, hepatitis C virus.
